Reactive hyperemia peripheral arterial tonometry as a measure of endothelial dysfunction in COPD

D. Schumann (Basel, Switzerland)

Source: International Congress 2017 – Extrapulmonary comorbidities in COPD
Session: Extrapulmonary comorbidities in COPD
Session type: Thematic Poster
Number: 699
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Schumann (Basel, Switzerland). Reactive hyperemia peripheral arterial tonometry as a measure of endothelial dysfunction in COPD. 699

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Peripheral arterial stiffness and endothelial dysfunction in pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load
Year: 2015

Arterial stiffness and endothelial dysfunction in stable COPD patients
Source: Annual Congress 2012 - COPD is not a pulmonary disease alone
Year: 2012

Endothelium function assesment with radial artery tonometry in COPD patients
Source: Annual Congress 2007 - Advances in respiratory mechanics
Year: 2007


Peripheral endothelial dysfunction in patients with pulmonary artery hypertension
Source: Eur Respir J 2007; 30: Suppl. 51, 344s
Year: 2007

Arterial stiffness in COPD is not related to endothelial function
Source: Annual Congress 2008 - Pathophysiology of COPD
Year: 2008


Comparison of peripheral arterial tonometry and invasive blood pressure in patients with obstructive sleep apnoea
Source: Eur Respir J 2001; 18: Suppl. 33, 519s
Year: 2001

Arterial vascular volume changes with haemodynamics in schistosomiasis-associated pulmonary arterial hypertension
Source: Eur Respir J, 57 (5) 2003914; 10.1183/13993003.03914-2020
Year: 2021



Outcomes of patients with decreased arterial oxyhaemoglobin saturation on pulmonary arterial hypertension drugs
Source: Virtual Congress 2021 – Therapy of pulmonary hypertension
Year: 2021


Pulmonary arterial hypertension in scleroderma – manifestation of systemic endothelial dysfunction
Source: Eur Respir J 2006; 28: Suppl. 50, 548s
Year: 2006

Endothelial dysfunction in patients with bronchial asthma with and without arterial hypertension
Source: Annual Congress 2009 - Asthma and comorbid conditions
Year: 2009


Daytime measurements underestimate nocturnal oxygen desaturations in pulmonary arterial and chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism
Year: 2012

Endothelial cells in the pathogenesis of pulmonary arterial hypertension
Source: Eur Respir J, 58 (3) 2003957; 10.1183/13993003.03957-2020
Year: 2021



Assessment of platelet dysfunction in patients with pulmonary arterial hypertension
Source: International Congress 2016 – Pulmonary hypertension: the clinic I
Year: 2016


Features of endothelial dysfunction in patients with COPD in combination with arterial hypertension
Source: Eur Respir J 2007; 30: Suppl. 51, 768s
Year: 2007

Arterial stiffness and endothelial dysfunction in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis?
Year: 2011

Quadriceps dysfunction in patients with pulmonary arterial hypertension
Source: Annual Congress 2007 - Pulmonary hypertension in the clinic
Year: 2007


Endothelial CFTR dysfunction and its involvement in the pathogenesis of pulmonary arterial hypertension
Source: Eur Respir J, 58 (2) 2101645; 10.1183/13993003.01645-2021
Year: 2021



Interstitial pressure and lung oedema in chronic hypoxia
Source: Eur Respir J 2011; 37: 943-949
Year: 2011



Assessment of the BODE index, arterial stiffness and endothelial dysfunction in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD comorbidities I
Year: 2012